| Hybrid myocardial revascularization: an integrated approach to coronary revascularization. | |
| | |
MedLine Citation:
|
PMID: 20333704 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Coronary artery bypass surgery is beneficial in patients with complex coronary artery disease. The longevity of the left internal mammary artery (LIMA) placed to the left anterior descending (LAD) artery (LIMA-LAD) is between 92-99% at 15 years, and contributes substantially to the survival advantage in patients treated with surgical revascularization. The long-term patency of saphenous vein grafts (SVGs), commonly used (>95%) in surgical revascularization procedures, is less well-established, with up to 26% of SVGs failing in the first year. In selected patients, particularly in those patients with vessels poorly suited to SVGs, hybrid myocardial revascularization (HMR) has been used, combining a minimally invasive approach to the LIMA-LAD with drug-eluting stent placement of the non-LAD vessels. The advantages and disadvantages of hybrid myocardial revascularization are reviewed in this report. |
| | |
Authors:
|
Jeffrey J Popma; Senthil Nathan; Robert C Hagberg; Kamal R Khabbaz |
Related Documents
:
|
8893574 - Hypertension increases the contractions to sumatriptan in the human internal mammary ar... 11157714 - Use of the internal mammary artery graft and in-hospital mortality and other adverse ou... 2319794 - Comparative anatomic studies of various arterial conduits for myocardial revascularizat... 3558184 - Anatomy of diaphragmatic circulation. 18496204 - Is an angiographically obliterated aneurysm always secure? 18295704 - Efficacy of a polyphosphazene nanocoat in reducing thrombogenicity, in-stent stenosis, ... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions Volume: 75 Suppl 1 ISSN: 1522-726X ISO Abbreviation: Catheter Cardiovasc Interv Publication Date: 2010 Mar |
Date Detail:
|
Created Date: 2010-03-29 Completed Date: 2010-06-17 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100884139 Medline TA: Catheter Cardiovasc Interv Country: United States |
Other Details:
|
Languages: eng Pagination: S28-34 Citation Subset: IM |
Copyright Information:
|
(c) 2010 Wiley-Liss, Inc. |
Affiliation:
|
Cardiovascular Division, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA. jpopma@bidmc.harvard.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty, Transluminal, Percutaneous Coronary*
/
adverse effects,
instrumentation Combined Modality Therapy Coronary Artery Bypass* / adverse effects Coronary Artery Disease / physiopathology, surgery, therapy* Drug-Eluting Stents Graft Occlusion, Vascular / etiology, prevention & control Humans Patient Selection Risk Assessment Time Factors Treatment Outcome Vascular Patency |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Contemporary principles of coronary chronic total occlusion recanalization.
Next Document: Contrast media and clotting: What is the evidence?